Ardelyx Inc (ARDX)
Healthcare
Biotechnology
5.00 $
-1.8%
vs. previous close
Closing price · As of: 31. Jul 2026
Ardelyx Inc (ARDX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -32 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -15 | -21 | -8.7 | -36 | -19 | 0.5 | 9.8 | -38 | -25 | 0.4 | 21 | -32 | -36 | |
| 0.6 | 0.3 | 0.4 | 0.4 | 0.6 | 0.5 | 0.5 | 0.6 | 0.6 | 0.9 | 0.9 | 0.9 | 3.4 | |
| 3.2 | 3.5 | 3.9 | 7.6 | 11 | 9.1 | 9.9 | 12 | 12 | 13 | 12 | 14 | 51 | |
| 2.2 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -2.4 | -33 | 15 | -19 | -15 | -9.5 | -6.2 | -11 | -19 | -9.2 | 7.7 | -7.7 | -28 | |
| 0.1 | 0.2 | 0.0 | 0.2 | 0.1 | 0.1 | 0.6 | 0.3 | 0.7 | 0.2 | 0.4 | 0.1 | 1.2 | |
| -59 | -33 | -30 | -2.6 | 24 | 2.3 | -42 | 2.9 | 35 | -51 | 3.8 | -10.0 | -22 | |
| – | – | 26 | – | – | – | – | – | – | – | – | – | – | |
| 12 | 0.7 | 0.3 | 3.2 | – | 4.3 | – | 1.5 | 1.0 | 2.8 | – | – | – | |
| – | – | – | – | – | 0.0 | 50 | 0.0 | 49 | 0.0 | 0.0 | – | – | |
| 12 | 58 | 26 | 53 | 1.6 | 2.7 | 49 | 1.5 | 50 | 2.8 | 0.6 | 5.4 | 58 | |
| -62 | 3.7 | -12 | 15 | 5.7 | 5.5 | 18 | -34 | 59 | -47 | 25 | -37 | 0.4 | |
| -15 | -22 | -8.8 | -36 | -20 | 0.4 | 9.2 | -39 | -26 | 0.2 | 21 | -32 | -37 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.